Twist Bioscience Corp Stock
Price
Target price
€86.74
€86.74
-0.570%
-0.5
-0.570%
-
09:56 / Tradegate
WKN: A2N7L2 / Symbol: TWST / Name: Twist Bioscience / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Twist Bioscience Corp Stock
The price for the Twist Bioscience Corp stock decreased slightly today. Compared to yesterday there is a change of -€0.500 (-0.570%).
Criterium "Revenue growth" is seen as the biggest plus for Twist Bioscience Corp stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Twist Bioscience Corp in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Twist Bioscience Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | -0.570% | -0.456% | 37.084% | 170.932% | 213.250% | 379.341% | -21.299% |
| Pacira Pharmaceuticals | 0.000% | 0.000% | 14.433% | 15.026% | 2.778% | -38.333% | -54.878% |
| Supernus Pharmaceuticals | 0.480% | 1.456% | 9.424% | 57.143% | -2.791% | 54.815% | 64.567% |
| Collegium Pharmaceutical Inc | 0.620% | 7.333% | 15.000% | 27.778% | -22.222% | 66.839% | 65.979% |
Comments
Twist Bioscience (TWST) had its "buy" rating reaffirmed by Guggenheim.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience (TWST) was upgraded by Canaccord Genuity Group Inc. to "strong-buy".
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience (TWST) had its "buy" rating reaffirmed by TD Cowen.
Show more
Ratings data for TWST provided by MarketBeat

